|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/42 | (2006.01) |
| A61K 39/155 | (2006.01) | ||
| C07K 16/10 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 3094353 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15737068.5 |
| Date of filing the European patent application | 2015-01-14 | |
| (97) | Date of publication of the European application | 2016-11-23 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-01 |
| (46) | Date of publication of the claims translation | 2020-08-10 |
| (86) | Number | PCT/US2015/011391 |
| Date | 2015-01-14 |
| (87) | Number | WO 2015/108967 |
| Date | 2015-07-23 |
| (30) | Number | Date | Country code |
| 201461927819 P | 2014-01-15 | US |
| (72) |
ULBRANDT, Nancy, US
KALLEWAARD-LELAY, Nicole, US
YUAN, Andy Q., US
RICHTER, Bettina, US
|
| (73) |
MedImmune Limited ,
Milstein Building
Granta Park, Cambridge
Cambridgeshire CB21 6GH,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | RSV specifiški antikūnai ir jų funkcionalios dalys |
| RSV-SPECIFIC ANTIBODIES AND FUNCTIONAL PARTS THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-12-17 | 12 | 289.00 EUR |
| 2027-01-14 |